Tempus AI receives FDA clearance for ECG-Low EF software
Tempus’ ECG-Low EF software analyses resting, non-ambulatory 12-lead ECG recordings to detect signs of LVEF below or equal to 40%.
Educating the global healthcare sector since 1998
Tempus’ ECG-Low EF software analyses resting, non-ambulatory 12-lead ECG recordings to detect signs of LVEF below or equal to 40%.
Give your business an edge with our Practical Patient Care